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ed mechanotransduction changes, neural and endocrine 
signals are altered in response to spaceflight and that these 
may have both negative (e.g. less muscle protein) and some 
positive consequences (e.g. healthier muscles), at least for 
invertebrates, with respect to health in space. Given that 
changes in circulating hormones are well documented with 
age and in astronauts, our view is that further research into 
the relationship between metabolic control, ageing, and ad-
aptation to the environment should be productive in ad-
vancing our understanding of the physiology of both space-
flight and ageing. 
 
© 2013 S. Karger AG, Basel 
 Introduction 
 Man has long shown a fascination for the stars and 
contrived to reach them since early history. This drive 
culminated in Yuri Gagarin’s demonstration that man 
can survive in space and Neil Armstrong and ‘Buzz’ Al-
drin’s demonstration that man can survive travel to, work 
upon, and return from the Moon. Currently, we live in an 
age when routinely living and working in space is a real-
ity. A select few have continuously manned our Interna-
tional Space Station (ISS) for more than 10 years, and a 
handful of individuals have purchased access to the ISS 
from companies. On the near horizon, several companies 
are promising cheaper widespread ‘space tourism’, which 
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 Abstract 
 The prospect of space travel continues to capture the imag-
ination. Several competing companies are now promising 
flights for the general population. Previously, it was recog-
nized that many of the physiological changes that occur with 
spaceflight are similar to those seen with normal ageing. This 
led to the notion that spaceflight can be used as a model of 
accelerated ageing and raised concerns about the safety of 
individuals engaging in space travel. Paradoxically, however, 
space travel has been recently shown to be beneficial to 
some aspects of muscle health in the tiny worm  Caenorhab-
ditis elegans. C. elegans  is a commonly used laboratory ani-
mal for studying ageing.  C. elegans displays age-related de-
cline of some biological processes observed in ageing hu-
mans, and about 35% of  C. elegans ’ genes have human 
homologs. Space flown worms were found to have de-
creased expression of a number of genes that increase life-
span when expressed at lower levels. These changes were 
accompanied by decreased accumulation of toxic protein 
aggregates in ageing worms’ muscles. Thus, in addition to 
spaceflight producing physiological changes that are similar 
to accelerated ageing, it also appears to produce some 
changes similar to delayed ageing. Here, we put forward the 
hypothesis that in addition to the previously well-appreciat-
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has been suggested to be a new consideration for doctors 
in a recent feature in the  British Medical Journal .
 Spaceflight is both a risky and stressful endeavour. The 
risk is highlighted by the increased incidence of acciden-
tal death in American astronauts  [1] and Russian cosmo-
nauts; the most commonly considered stressors of flight 
are altered gravity and increased chance of irradiation. 
The increased G forces associated with launch and land-
ing have long been known, from studies of fighter pilots, 
to pose potential operational problems. Intuitively, we 
also realize that the ‘micro-gravity’ that arises on orbital 
missions as the result of being in a state of constant free 
fall around the Earth is also a physiological stress (when 
is falling not stressful?). Similarly, we know that exposure 
to increased radiation can lead to cancer. However, to 
date, cataracts and not cancer have been documented to 
correlate with the increased radiation some astronauts 
have received during spaceflight  [1] . In contrast to these 
well-appreciated risks and stresses, we often forget that in 
the process of identifying and militating against the phys-
ical risks of spaceflight, via spacecraft and subsystem de-
sign, that iatrogenic problems can arise. For example, the 
American use of iodine in water purification systems 
leading to thyroid problems  [1] .
 Historically, space life sciences and space medicine re-
search have focused on documenting the changes ob-
served in response to spaceflight and militating against 
undesirable physiological changes in space travellers. 
Consequently, there is a vast body of data describing the 
biological response of a variety of organisms to space-
flight  [2] and a general consensus that short-term orbital 
flight is safe for man, but that we lack the evidence base 
to comment on the safety of human space travel beyond 
low Earth orbit  [3] . However, it is widely acknowledged 
that a key barrier to travel beyond low Earth orbit is in-
creased exposure to radiation  [3] .
 In cataloguing the biological effects of spaceflight, 2 
main themes have emerged. First, in man, spaceflight 
produces a host of changes that induce a state of frailty 
akin to ageing  [4] ; notably, most of these changes are 
quickly reversed upon re-adaptation to life on Earth. Sec-
ond, in all organisms yet studied, growth and metabolism 
are altered in flight. This latter point may not be so sur-
prising if one considers that spacecraft are closed ecolog-
ical systems and that adaptation to the environment re-
quires energy. Here, we briefly recap past notions of 
spaceflight as a model for accelerated ageing, the health 
concerns expressed for individuals engaging in space-
flight activities and the alterations in metabolism in re-
sponse to spaceflight, and examine some recent data 
which suggest that space travel may cause some physio-
logical changes akin to delayed ageing. We close by re-
proposing an idea from the dawn of the space age: altered 
metabolism underlies the physiological alterations ob-
served during spaceflight.
 Spaceflight as a Model of ‘Accelerated Ageing’ 
 The notion that spaceflight may be a model for accel-
erated ageing has recently been reviewed  [4] . During both 
spaceflight and ageing, muscle and bone are lost, balance 
and coordination problems occur, and cardiovascular ca-
pacity is reduced. With spaceflight and bed rest, these 
changes are observed roughly 10-fold faster than with 
ageing. Additionally, unlike ageing, the physiological 
changes observed with spaceflight and bed rest are large-
ly, if not completely, reversed upon re-adaptation to life 
on Earth or the non-bedridden state. Thus, it has been 
postulated that the lack of mechanical load upon the 
mechanotransduction-mechanochemical transduction 
systems underlies many of the changes seen with space-
flight, bed rest, sedentary lifestyle, and ageing. In support 
of this theory is the observation that mechanosensitive 
enzymes, such as focal adhesion kinase, are present in 
lower amounts and with lower activity in human muscle 
that has atrophied as the result of immobilization  [5] , 
while they are present in higher amounts and with higher 
activity in human muscle that has hypertrophied in re-
sponse to exercise  [6] .
 Concern for Individuals Engaged in Space Travel 
 Despite the available evidence suggesting that most of 
the physiological changes experienced during spaceflight 
are reversed upon re-adaptation to life on Earth and the 
lack of evidence of long-term negative consequences of 
spaceflight  [1] , a cautionary principle still tends to be em-
ployed in discussion of the health risks of spaceflight. For 
example, an international committee has produced a set of 
medical standards for certification of non-professional 
space travellers to be ‘space flight participants’ onboard the 
ISS by ‘relaxing’ the criteria used for professional astro-
nauts and cosmonauts  [7] . Included within the criteria that 
can disqualify prospective participants are many condi-
tions that commonly present in ageing individuals. For ex-
ample, glaucoma, chronic obstructive pulmonary disease, 
malignant tumours, hypertension, hypotension, coronary 
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disease, diabetes, history of cerebrovascular accident, and 
neurodegenerative diseases. From an operational perspec-
tive, this caution makes sense. The ISS was expensive to 
build and remains expensive to operate. Flying individuals 
who could compromise this international investment as 
the result of exacerbation of an underlying condition 
would certainly lead to an international uproar and legal 
actions. From a scientific perspective, this list of disqualify-
ing conditions suggests that adaptation to spaceflight re-
sults from more than a simple lack of mechanical load.
 Spaceflight Alters Metabolism 
 The 1960s was a decade of change. Not only did the first 
men set foot on the Moon, but also the molecular biology 
revolution began. Prior to the molecular biology revolu-
tion, much of biology was devoted to understanding how 
metabolism controlled biology. Unsurprisingly, older 
studies of organisms in space document that growth and 
metabolism are altered, while newer studies document 
changes in gene expression and suggest molecular path-
ways that regulate such changes  [1] . In astronauts, meta-
bolic effects of spaceflight include loss of body weight and 
negative metabolic balances of nitrogen, phosphorus, and 
calcium  [8] . Some of these changes are thought to be due 
to changes in fluid homeostasis  [8] , some due to decreased 
energy intake which occurs for incompletely understood 
reasons that may include sensory and/or neuronal altera-
tions affecting palatability and/or satiety  [9] , and some for 
still unknown reasons which might include altered pro-
tein homeostasis in muscle which may occur due to al-
tered mechanical load. If one assumes that decreased en-
ergy production results in a necessary decline in energy 
available to combat stress or infection and also for run-
ning maintenance and/or repair processes, the impact of 
spaceflight upon metabolism is sufficient to account for 
increased frailty. This suggestion is similar to some theo-
ries of ageing and/or age-related decline that postulate de-
creased energy production from the mitochondria occurs 
with age and contributes to increased frailty.
 C. elegans as a Model for Studies of Spaceflight and 
Ageing 
 The tiny worm  C. elegans is a common laboratory an-
imal. Prior to the initial studies of  C. elegans in space, 
which revealed that worms are susceptible to the muta-
genic effects of increased radiation in space independent-
ly of ‘microgravity’  [10] , it was proposed that this worm 
could be used for studies involving spaceflight and ageing 
 [11] .
 C. elegans  was the first multicellular animal to have its 
genome sequenced, which gave us the tools and experi-
ence needed to sequence the human genome. These ef-
forts inform us that roughly 35% of  C. elegans ’ genes have 
identified human homologs. Consequently,  C. elegans re-
mains at the forefront of animals used in experiments to 
understand how the genome controls health. Other ex-
periments with this worm have led to the discovery of 
programmed cell death, the phenomena of gene silencing 
by RNA interference, the discovery of microRNAs, evo-
lutionarily conserved genes that contribute to maximal 
lifespan  [12] , and a reproducible genomic response to 
spaceflight  [13] (and subsequent flights).
 C. elegans has a short lifespan and rapid generation 
time, which make it an ideal animal for prospective stud-
ies of ageing and also evolution. As with other poikilo-
therms,  C. elegans displays an inverse relationship be-
tween temperature of cultivation and lifespan. While the 
mechanism(s) underlying this relationship remain to be 
established, the observation suggests that  C. elegans ’ life-
span is responsive to the environment, possibly via effects 
upon metabolism. Like many other animals, including 
homeotherms,  C. elegans also displays lifespan extension 
when grown on any one of several restricted diets, again 
possibly via effects upon energy metabolism or resulting 
from altered substrate utilization. In the case of growth in 
a chemically defined diet versus the standard laboratory 
diet of  Escherichia coli , the effects of temperature and diet 
are independent of each other, and various parameters of 
 C. elegans ’ life history scale identically as a percentage of 
maximal lifespan in response to temperature on the 2 di-
ets  [14] . Thus, there appear to be at least 2 mechanisms 
by which environmental factors (e.g. temperature and 
diet) impact upon  C. elegans ’ lifespan.
 In contrast to the incomplete molecular mechanistic 
understanding that underlies the clearly documented im-
pact of environmental factors upon  C. elegans ’ lifespan, 
several genes and putative molecular regulatory pathways 
have been identified. One of the earliest discovered and 
arguably best-studied pathways is the  daf-2 ,  age-1 ,  daf-16 
pathway. Mutations in these genes, and others, have been 
shown to act in a common signalling pathway to control 
lifespan  [15] . These genes encode an insulin/insulin-like 
growth factor receptor, its downstream signalling kinase 
phosphoinositide-3-kinase, and the DAF-16/FOXO 
(FOrkhead BoX O) transcription factor. At least part of 
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lifespan is achieved via DAF-2 and AGE-1 signalling al-
tering the activity of DAF-16/FOXO. As DAF-16/FOXO 
is a transcription factor, these alterations result in chang-
es in transcription of genes controlled by DAF-16/FOXO. 
The transcription of several hundred genes is affected in 
 daf-2 mutants in a DAF-16-dependent fashion. This find-
ing suggests that insulin/insulin-like signalling control of 
lifespan is complex. Given that DAF-2 is an insulin/insu-
lin-like growth factor receptor that is well known to con-
trol energy metabolism in mammals, it is unsurprising 
that many of the genes displaying altered expression in 
long-lived  daf-2 mutants are genes involved in energy 
metabolism. To date, the precise relationship between 
DAF-16-controlled alteration of energy metabolism and 
lifespan remains incompletely defined in  C. elegans .
 C. elegans is used not only to understand what envi-
ronmental and genetic factors control lifespan and how 
they do so, but also to understand age-related diseases 
and changes in tissues and biological processes with age. 
Intriguingly, expressions of mutant human proteins that 
cause neurodegeneration with age in man also do so in  C. 
elegans (for example: β-amyloid, tau, and α-synuclein). 
Similarly, both worm and man show an age-related de-
cline in mobility that is an accurate predictor of death, 
sarcopenia (the decline in muscle size and function with 
age), and a decline in expression of mitochondrial en-
zymes required for production of energy. The fact that 
there is a decline in mitochondrial enzymes required for 
production of energy with age may be a potential expla-
nation for the decline of tissues with age and also the ap-
pearance of age-related diseases such as the neurodegen-
eration disorders. While the evidence for a causal link be-
tween mitochondrial decline, tissue decline, and ageing 
disorders is currently lacking, mutations in  daf-2  [16] or 
 age-1  [17] are sufficient to delay the onset of movement 
decline in  C. elegans , perhaps again suggesting a link be-
tween energy metabolism and ageing.
 Could Spaceflight Increase  C. elegans ’ Lifespan? 
 In contrast to the concerns with spaceflight producing 
physiological changes akin to accelerated ageing and/or 
exacerbating common conditions associated with ageing, 
recent data suggest that spaceflight may have some posi-
tive consequences for the ageing process. Well, at least in 
worms.
 A series of flights examining alterations in gene ex-
pression in space flown worms all found decreases in 
mRNA levels for genes whose expression is known to be 
controlled by DAF-16/FOXO  [13] (and subsequent 
flights). These results suggest both that insulin-like sig-
nalling may influence the gene expression changes in re-
sponse to spaceflight to produce the subsequent biologi-
cal alterations, and that, perhaps, worms grown in space 
live longer than their Earthbound counterparts.
 To directly test if depressed expression of some identi-
fied genes can lead to increased lifespan, 11 genes that 
displayed large depressions in mRNA levels in response 
to spaceflight were selected for evaluation. All 11 selected 
genes were previously known to be involved in neuronal 
or endocrine signalling but not regulation of lifespan. The 
inactivation, by loss- or reduction-of-function mutation 
and/or RNAi, of 7 of the 11 selected genes resulted in in-
creased lifespan  [18] . Thus, at least some of the gene ex-
pression changes observed in spaceflight can increase 
lifespan (when knockdown occurs independently of ad-
ditional induced depressions in gene expression). This 
finding raises the questions of whether spaceflight can di-
rectly increase lifespan, at least in a worm, and how can 
spaceflight induce both frailty and longevity? Clearly, fur-
ther experiments are required to answer both questions, 
and direct measurement of  C. elegans ’ lifespan on board 
the ISS is possible, resources permitting.
 Reconciling Increased Frailty against Increased 
Longevity 
 With regards to spaceflight inducing both frailty and 
longevity, one possibility is that, as posed in the 1960’s, 
altered energy metabolism is induced by spaceflight and 
this accounts for the physiological changes observed  [19] . 
It is important to remember that what we may label as 
‘accelerated ageing’ or frailty is context dependent. That 
is, most of the physiological changes observed in space-
flight are quickly reversed upon return to Earth and there-
fore are not really accelerated ageing or a long-term state 
of frailty, but rather physiological adaptation to space-
flight (including the closed ecosystem of the spacecraft). 
Various types of diet restriction are also known to induce 
altered metabolism, frailty, and longevity. This is true of 
 C. elegans , where DAF-16/FOXO appears to control al-
tered metabolism, increased risk of death during repro-
duction, and longevity in response to growth in a fully 
chemical diet  [14] . The diet restriction data demonstrate 
that it is possible to have increased frailty and longevity. 
However, the frailty with diet restriction is context de-
pendent. That is, in the absence of reproduction or other 




























 Honda  /Honda  /Narici  /Szewczyk  
 
 Gerontology 2014;60:138–142 
DOI: 10.1159/000354772
142
not be noted in worms grown in a chemically defined diet. 
Similarly, changes in muscle in response to spaceflight are 
largely thought to be adaptive to the spaceflight environ-
ment, with frailty noted upon return to Earth  [3] . In this 
context, it is particularly interesting to note that not only 
do space flown worms experience patterns of gene ex-
pression in muscle, as experienced by astronauts as well 
(for example less myosin and less MyoD transcription 
factor), but also worms with a mutation that induces dys-
trophy appear less dystrophic in space  [20] , and worms 
expressing a 35-glutamine repeat protein in muscle dis-
play less protein aggregation than Earthbound counter 
parts  [18] . Thus, changes observed in muscle in space 
could be labelled as increased frailty (in the context of the 
ability to deal with a mechanical stress), but by other mea-
sures (e.g. less likely to develop myopathies) they are 
‘healthier’ than on Earth.
 In conclusion, alterations in energy metabolism occur 
with both spaceflight and ageing. While not yet proven 
via interventional studies, in some cases the alterations in 
energy metabolism are theoretically sufficient to account 
for the physiological changes observed, particularly in-
creased frailty. Thus, it is plausible that neuroendocrine 
control of energy metabolism may be a key determinant 
and potential point of therapeutic intervention for the 
‘frailty’ associated with both spaceflight and ageing. How-
ever, a potential key challenge is that as with endocrine 
disorders in the clinic, where it is frequently the case that 
balance is key and ‘too little’ or ‘too much’ signal is prob-
lematic, with both spaceflight and ageing the ‘frailty’ may 
be adaptive and intervention may impair future adapta-
tions that may be required.
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